Alkermes (ALKS) Other Accumulated Expenses (2011 - 2026)
Alkermes (ALKS) reported Other Accumulated Expenses of $136.8 million for Q1 2026, up 64.63% year-over-year from $83.1 million in Q1 2025, and up 37.94% quarter-over-quarter from $99.2 million in Q4 2025.
Alkermes (ALKS) Other Accumulated Expenses (2011 - 2026) Analysis & Trends
Alkermes (ALKS) has 16 years of Other Accumulated Expenses data on file, last reported at $136.8 million in Q1 2026.
- Other Accumulated Expenses for Q1 2026 came in at $136.8 million, up 64.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $136.8 million (up 64.63% YoY), and the FY2025 annual result was $99.2 million, up 44.26% from the prior year.
- Other Accumulated Expenses improved to $136.8 million in Q1 2026 per ALKS's latest filing, from $99.2 million in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $136.8 million in Q1 2026 and troughed at $67.3 million in Q3 2024.
- A 5-year average of $93.3 million and a median of $91.0 million in 2022 frame the typical range for Other Accumulated Expenses.
- The sharpest annual moves came in 2024 and 2026: Other Accumulated Expenses dropped 25.12% in 2024, then soared 64.63% in 2026.
- A 5-year view of Other Accumulated Expenses shows it stood at $108.2 million in 2022, then declined by 15.12% to $91.8 million in 2023, then retreated by 25.12% to $68.7 million in 2024, then surged by 44.26% to $99.2 million in 2025, then jumped by 37.94% to $136.8 million in 2026.
- Business Quant data shows ALKS's Other Accumulated Expenses at $136.8 million in Q1 2026, $99.2 million in Q4 2025, and $79.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 136.79 Mn |
| Dec 31, 2025 | 99.17 Mn |
| Sep 30, 2025 | 79.79 Mn |
| Jun 30, 2025 | 90.00 Mn |
| Mar 31, 2025 | 83.09 Mn |
| Dec 31, 2024 | 68.74 Mn |
| Sep 30, 2024 | 67.26 Mn |
| Jun 30, 2024 | 85.64 Mn |
| Mar 31, 2024 | 81.59 Mn |
| Dec 31, 2023 | 91.81 Mn |
| Sep 30, 2023 | 88.45 Mn |
| Jun 30, 2023 | 98.35 Mn |
| Mar 31, 2023 | 105.30 Mn |
| Dec 31, 2022 | 108.16 Mn |
| Sep 30, 2022 | 117.06 Mn |
| Jun 30, 2022 | 93.90 Mn |
| Mar 31, 2022 | 91.02 Mn |
| Dec 31, 2021 | 75.51 Mn |
| Sep 30, 2021 | 101.44 Mn |
| Jun 30, 2021 | 68.05 Mn |